ArticleClinicoEconomics and outcomes research : CEOR2026
Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective.
James R Bentham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.